---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-028900"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:45:53.971978+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics stockholders elect Garo Armen and Barbara Ryan as Class II directors, ratify KPMG as auditor

## Summary
- Garo Armen received 29,157,446 for and 282,326 withheld; Barbara Ryan 29,193,530 for and 246,242 withheld.
- KPMG LLP ratified as independent auditor for FY2023 with 30,644,494 for, 5,764 against, 110,413 abstentions.
- Quorum of 30,760,671 shares (89.6% of outstanding) present at June 13, 2023 Annual Meeting.

## SEC filing metadata
- accession: 0000950170-23-028900
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/0000950170-23-028900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/inkt-20230613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-028900
- JSON: https://secwatch.observer/filing/0000950170-23-028900.json
- Plain text: https://secwatch.observer/filing/0000950170-23-028900.txt

## Key facts
- Shareholder Votes
  MiNK Therapeutics, Inc. shareholders approved Election of Garo Armen and Barbara Ryan as Class II directors at the 2023-06-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: Class II Director Nominees For Against Withheld Broker Non-Votes Garo Armen 29,157,446 0 282,326 1,320,899 Barbara Ryan 29,193,530 0 246,242 1,320,899
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/0000950170-23-028900-index.htm
- Shareholder Votes
  MiNK Therapeutics, Inc. shareholders approved Ratification of appointment of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-13
  source text: The votes cast at the Annual Meeting were as follows: For Against Withheld Broker Non-Votes 30,644,494 5,764 110,413 NA
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840229/000095017023028900/0000950170-23-028900-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.